Targeted Translation Research Accelerator — chronic conditions — diabetes and heart disease
The Australian Government is investing in research to improve the lives of patients with chronic conditions through new methods of prevention, treatments and cures.
What we’re funding
$125 million over 9 years to establish a Targeted Translation Research Accelerator in chronic conditions, particularly diabetes and heart disease.
The purpose of this research funding is to:
- improve the lives of patients living with chronic disease
- create new jobs
- lift Australia’s reputation as a health and medical research powerhouse.
This program will:
- support early stage health and medical research discoveries to reach proof-of-concept and progress to human clinical trials
- establish philanthropic and business co-invest arrangements to support increased efforts.
Why it’s important
- Chronic conditions impact millions of Australians.
- The progress of early stage health and medical research often lacks investment.
- It will help innovations progress to late stage research and commercial success with support from philanthropic and business co-funding.
An expert advisory committee will be established to identify areas of research priority, co-funding models with business and philanthropists, and mechanisms for support including grants. The Australian Medical Research Advisory Board will lead the committee.